Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769353 · ClinicalTrials.gov registry record · NA
Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00769353: Completed NA study, sponsored by University of Pittsburgh.
NCT00769353 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 90 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00769353, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This research will examine the impact of brain activity, cognitive processing immune functioning, and gastrointestinal functioning on depressive symptoms and response to a psychotherapeutic intervention in youths with Inflammatory Bowel Disease (IBD).
Primary Outcome
Compare neurological measures (via brain scan, pupil dilation and laboratory blood values) in depressed individuals with IBD, non-depressed individuals with IBD and healthy controls.
Interventions
- BEHAVIORAL Primary and Secondary Coping Enhancement Training
- BEHAVIORAL Supportive Non-directive Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2008-01 |
| Est. Completion | 2014-01 |
| Phase | NA |
What the finished NCT00769353 record still lists
NCT00769353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Primary and Secondary Coping Enhancement Training is the first listed.
NCT00769353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00769353 about?
NCT00769353 is a clinical study titled "Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness". This research will examine the impact of brain activity, cognitive processing immune functioning, and gastrointestinal functioning on depressive symptoms and response to a psychotherapeutic intervention in youths with Inflammatory Bowel Disease (IBD).
What is the current status of trial NCT00769353?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2008-01. Estimated completion is 2014-01.
What interventions are being tested in trial NCT00769353?
The interventions under investigation include: Primary and Secondary Coping Enhancement Training (BEHAVIORAL), Supportive Non-directive Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT00769353?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00769353's enrollment target sits among peer trials
90 941st of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia